Core Viewpoint - The company, Dian Diagnostics, has successfully obtained approval for a key research project focused on rapid diagnosis of respiratory infections, specifically pertussis, through a magnetic fluorescence immunochromatography detection platform [1] Group 1: Project Approval - The Guangxi Science and Technology Department has officially announced the first batch of proposed projects for the Guangxi Science and Technology Plan for 2026 [1] - Dian Diagnostics' subsidiary, Guangxi Dian, in collaboration with Nanning Fourth People's Hospital and Guangdong Provincial People's Hospital, submitted the project titled "Empowerment Action Plan" [1] Group 2: Research Focus - The project aims to address technical challenges in the application of magnetic fluorescence immunochromatography detection technology for rapid diagnosis of pertussis and other respiratory infections [1] - The research team will collaborate with multiple scientific research institutions to develop a faster, more accurate, and easily promotable detection solution [1] Group 3: Clinical Impact - The initiative is designed to facilitate early and precise clinical diagnosis and prevention of respiratory infections [1]